Blockchain Registration Transaction Record

Gut Microbiome Emerges as Key Player in Cancer Therapy Revolution

Discover how the gut microbiome drives cancer progression and therapy response. A special issue in Cancer Biology & Medicine reveals microbial mechanisms, probiotics, and tumor-resident bacteria as new targets for precision oncology.

This news matters because it reveals a paradigm shift in cancer treatment: the microbiome is not just a bystander but a potential therapeutic target. Understanding how gut and tumor-resident bacteria influence cancer progression and treatment response opens avenues for non-invasive diagnostics, personalized probiotics, and microbiome-based therapies that could enhance immunotherapy efficacy, reduce side effects, and improve outcomes for patients with various cancers, including colorectal, liver, gastric, and pancreatic cancers. For the general public, it underscores the importance of gut health in cancer prevention and treatment, potentially leading to new dietary and probiotic recommendations.